Browsing Centre for Cancer Prevention by Subject "Neoplasms"
Now showing items 1-8 of 8
-
Acceptability of aspirin for cancer preventive therapy: a survey and qualitative study exploring the views of the UK general population.
(BMJ Publishing Group, 2023-12-18)OBJECTIVES: Aspirin could be offered for colorectal cancer prevention for the UK general population. To ensure the views of the general population are considered in future guidance, we explored public perceptions of aspirin ... -
Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain.
(2024-04)BACKGROUND: Trials are underway to test the clinical utility of multi-cancer early detection (MCED) blood tests for screening asymptomatic individuals. We sought to understand the acceptability of MCED blood test screening ... -
Cancer incidence in English children, adolescents and young people: past trends and projections to 2030.
(2017-12-05)BACKGROUND: Estimating the future incidence of cancer is important to establish sufficient service provision, however, work in this area is limited for cancer in children, adolescents, and young adults (aged 0-24). METHODS: ... -
Changing from face-to-face to virtual meetings due to the COVID-19 pandemic: protocol for a mixed-methods study exploring the impact on cancer multidisciplinary team (MDT) meetings.
(2023-04-19)INTRODUCTION: In the UK, the National Cancer Plan (2000) requires every cancer patient's care to be reviewed by a multidisciplinary team (MDT). Since the introduction of these guidelines, MDTs have faced escalating demands ... -
Clone competition as a mechanism to reduce tumor formation.
(2021-12-20)With age, clones carrying somatic mutations in well-known cancer driver genes progressively populate adult tissues, yet cancer transformation is rare. In a recent issue of Nature, Colom et al. showed that competition between ... -
Considerations for using potential surrogate endpoints in cancer screening trials.
(Elsevier, 2024-04-29)The requirement of large-scale expensive cancer screening trials spanning decades creates considerable barriers to the development, commercialisation, and implementation of novel screening tests. One way to address these ... -
Impact of screening participation on modelled mortality benefits of a multi-cancer early detection test by socioeconomic group in England.
(2024-05-09)BACKGROUND: Cancer burden is higher and cancer screening participation is lower among individuals living in more socioeconomically deprived areas of England, contributing to worse health outcomes and shorter life expectancy. ... -
Priorities for implementation research on diagnosing cancer in primary care: a consensus process.
(2023-11-27)BACKGROUND: The early detection and diagnosis of cancer to reduce avoidable mortality and morbidity is a challenging task in primary health care. There is a growing evidence base on how to enable earlier cancer diagnosis, ...